Wednesday October 28, 2020

A coup for stroke treatment as Perfuze raises €3m seed funding

3rd February, 2019
Wayne Allen, co-founder of Profuze Pic: Aengus McMahon

Company: Perfuze

Done Deal:€3m funding

The clincher:“Perfuze has a technology with the potential to significantly improve outcomes for stroke patients” - John Yianni, Earlybird

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader



Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.



€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.




90 Day Pass

You can cancel any time.

2 Yearly



Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures

Tom Maguire | 5 months ago

What’s coming up today and what you might have missed

Hannah O’Brien | 10 months ago